United States Cidofovir Market Report 2016

December 2016 | 107 pages | ID: U249B5BB1AFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cidofovir

Revenue, means the sales value of Cidofovir

This report studies sales (consumption) of Cidofovir in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Agenus, Inc. (US)
• AiCuris GmbH & Co.KG (Germany)
• Astellas Pharma, Inc. (Japan)
• Clinigen Group (UK)
• Cytogenix, Inc. (US)
• Genocea Biosciences (US)
• GlaxoSmithKline Plc. (UK)
• Lumavita AG (Switzerland)
• NanoBio Corporation (US)
• NanoViricides, Inc. (US)
• Novartis International AG (Switzerland)
• Sanofi (France)
• Starpharma Holdings Limited (Australia)
• Vical (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cidofovir in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Cidofovir Market Report 2016

1 CIDOFOVIR OVERVIEW

1.1 Product Overview and Scope of Cidofovir
1.2 Classification of Cidofovir
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cidofovir
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cidofovir (2011-2021)
  1.4.1 United States Cidofovir Sales and Growth Rate (2011-2021)
  1.4.2 United States Cidofovir Revenue and Growth Rate (2011-2021)

2 UNITED STATES CIDOFOVIR COMPETITION BY MANUFACTURERS

2.1 United States Cidofovir Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cidofovir Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cidofovir Average Price by Manufactures (2015 and 2016)
2.4 Cidofovir Market Competitive Situation and Trends
  2.4.1 Cidofovir Market Concentration Rate
  2.4.2 Cidofovir Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CIDOFOVIR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cidofovir Sales and Market Share by Type (2011-2016)
3.2 United States Cidofovir Revenue and Market Share by Type (2011-2016)
3.3 United States Cidofovir Price by Type (2011-2016)
3.4 United States Cidofovir Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CIDOFOVIR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cidofovir Sales and Market Share by Application (2011-2016)
4.2 United States Cidofovir Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CIDOFOVIR MANUFACTURERS PROFILES/ANALYSIS

5.1 Agenus, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cidofovir Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Agenus, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AiCuris GmbH & Co.KG (Germany)
  5.2.2 Cidofovir Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AiCuris GmbH & Co.KG (Germany) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Astellas Pharma, Inc. (Japan)
  5.3.2 Cidofovir Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Astellas Pharma, Inc. (Japan) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Clinigen Group (UK)
  5.4.2 Cidofovir Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Clinigen Group (UK) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Cytogenix, Inc. (US)
  5.5.2 Cidofovir Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Cytogenix, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Genocea Biosciences (US)
  5.6.2 Cidofovir Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Genocea Biosciences (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 GlaxoSmithKline Plc. (UK)
  5.7.2 Cidofovir Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlaxoSmithKline Plc. (UK) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lumavita AG (Switzerland)
  5.8.2 Cidofovir Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lumavita AG (Switzerland) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 NanoBio Corporation (US)
  5.9.2 Cidofovir Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 NanoBio Corporation (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 NanoViricides, Inc. (US)
  5.10.2 Cidofovir Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 NanoViricides, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Novartis International AG (Switzerland)
5.12 Sanofi (France)
5.13 Starpharma Holdings Limited (Australia)
5.14 Vical (US)

6 CIDOFOVIR MANUFACTURING COST ANALYSIS

6.1 Cidofovir Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cidofovir

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cidofovir Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cidofovir Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CIDOFOVIR MARKET FORECAST (2016-2021)

10.1 United States Cidofovir Sales, Revenue Forecast (2016-2021)
10.2 United States Cidofovir Sales Forecast by Type (2016-2021)
10.3 United States Cidofovir Sales Forecast by Application (2016-2021)
10.4 Cidofovir Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cidofovir
Table Classification of Cidofovir
Figure United States Sales Market Share of Cidofovir by Type in 2015
Table Application of Cidofovir
Figure United States Sales Market Share of Cidofovir by Application in 2015
Figure United States Cidofovir Sales and Growth Rate (2011-2021)
Figure United States Cidofovir Revenue and Growth Rate (2011-2021)
Table United States Cidofovir Sales of Key Manufacturers (2015 and 2016)
Table United States Cidofovir Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cidofovir Sales Share by Manufacturers
Figure 2016 Cidofovir Sales Share by Manufacturers
Table United States Cidofovir Revenue by Manufacturers (2015 and 2016)
Table United States Cidofovir Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cidofovir Revenue Share by Manufacturers
Table 2016 United States Cidofovir Revenue Share by Manufacturers
Table United States Market Cidofovir Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cidofovir Average Price of Key Manufacturers in 2015
Figure Cidofovir Market Share of Top 3 Manufacturers
Figure Cidofovir Market Share of Top 5 Manufacturers
Table United States Cidofovir Sales by Type (2011-2016)
Table United States Cidofovir Sales Share by Type (2011-2016)
Figure United States Cidofovir Sales Market Share by Type in 2015
Table United States Cidofovir Revenue and Market Share by Type (2011-2016)
Table United States Cidofovir Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cidofovir by Type (2011-2016)
Table United States Cidofovir Price by Type (2011-2016)
Figure United States Cidofovir Sales Growth Rate by Type (2011-2016)
Table United States Cidofovir Sales by Application (2011-2016)
Table United States Cidofovir Sales Market Share by Application (2011-2016)
Figure United States Cidofovir Sales Market Share by Application in 2015
Table United States Cidofovir Sales Growth Rate by Application (2011-2016)
Figure United States Cidofovir Sales Growth Rate by Application (2011-2016)
Table Agenus, Inc. (US) Basic Information List
Table Agenus, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Agenus, Inc. (US) Cidofovir Sales Market Share (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Basic Information List
Table AiCuris GmbH & Co.KG (Germany) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Cidofovir Sales Market Share (2011-2016)
Table Astellas Pharma, Inc. (Japan) Basic Information List
Table Astellas Pharma, Inc. (Japan) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma, Inc. (Japan) Cidofovir Sales Market Share (2011-2016)
Table Clinigen Group (UK) Basic Information List
Table Clinigen Group (UK) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Clinigen Group (UK) Cidofovir Sales Market Share (2011-2016)
Table Cytogenix, Inc. (US) Basic Information List
Table Cytogenix, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytogenix, Inc. (US) Cidofovir Sales Market Share (2011-2016)
Table Genocea Biosciences (US) Basic Information List
Table Genocea Biosciences (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genocea Biosciences (US) Cidofovir Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Cidofovir Sales Market Share (2011-2016)
Table Lumavita AG (Switzerland) Basic Information List
Table Lumavita AG (Switzerland) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lumavita AG (Switzerland) Cidofovir Sales Market Share (2011-2016)
Table NanoBio Corporation (US) Basic Information List
Table NanoBio Corporation (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoBio Corporation (US) Cidofovir Sales Market Share (2011-2016)
Table NanoViricides, Inc. (US) Basic Information List
Table NanoViricides, Inc. (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoViricides, Inc. (US) Cidofovir Sales Market Share (2011-2016)
Table Novartis International AG (Switzerland) Basic Information List
Table Novartis International AG (Switzerland) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International AG (Switzerland) Cidofovir Sales Market Share (2011-2016)
Table Sanofi (France) Basic Information List
Table Sanofi (France) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi (France) Cidofovir Sales Market Share (2011-2016)
Table Starpharma Holdings Limited (Australia) Basic Information List
Table Starpharma Holdings Limited (Australia) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Starpharma Holdings Limited (Australia) Cidofovir Sales Market Share (2011-2016)
Table Vical (US) Basic Information List
Table Vical (US) Cidofovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical (US) Cidofovir Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cidofovir
Figure Manufacturing Process Analysis of Cidofovir
Figure Cidofovir Industrial Chain Analysis
Table Raw Materials Sources of Cidofovir Major Manufacturers in 2015
Table Major Buyers of Cidofovir
Table Distributors/Traders List
Figure United States Cidofovir Production and Growth Rate Forecast (2016-2021)
Figure United States Cidofovir Revenue and Growth Rate Forecast (2016-2021)
Table United States Cidofovir Production Forecast by Type (2016-2021)
Table United States Cidofovir Consumption Forecast by Application (2016-2021)